NO172493C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav

Info

Publication number
NO172493C
NO172493C NO880297A NO880297A NO172493C NO 172493 C NO172493 C NO 172493C NO 880297 A NO880297 A NO 880297A NO 880297 A NO880297 A NO 880297A NO 172493 C NO172493 C NO 172493C
Authority
NO
Norway
Prior art keywords
hydroxymethylpenicillan
beta
derivatives
acids
substituted
Prior art date
Application number
NO880297A
Other languages
English (en)
Norwegian (no)
Other versions
NO880297L (no
NO172493B (no
NO880297D0 (no
Inventor
Yuhpyng Liang Chen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO880297D0 publication Critical patent/NO880297D0/no
Publication of NO880297L publication Critical patent/NO880297L/no
Publication of NO172493B publication Critical patent/NO172493B/no
Publication of NO172493C publication Critical patent/NO172493C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO880297A 1987-01-27 1988-01-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav NO172493C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US731987A 1987-01-27 1987-01-27

Publications (4)

Publication Number Publication Date
NO880297D0 NO880297D0 (no) 1988-01-25
NO880297L NO880297L (no) 1988-07-28
NO172493B NO172493B (no) 1993-04-19
NO172493C true NO172493C (no) 1993-07-28

Family

ID=21725481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880297A NO172493C (no) 1987-01-27 1988-01-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav

Country Status (25)

Country Link
EP (1) EP0276942B1 (da)
JP (1) JPS63246384A (da)
KR (1) KR900005050B1 (da)
CN (1) CN1014710B (da)
AT (1) ATE74359T1 (da)
AU (2) AU590142B2 (da)
CA (1) CA1288091C (da)
DD (1) DD279882A5 (da)
DE (1) DE3869630D1 (da)
DK (1) DK36788A (da)
ES (1) ES2031589T3 (da)
FI (1) FI880334A (da)
GR (1) GR3004460T3 (da)
HU (1) HU205765B (da)
IE (1) IE60348B1 (da)
IL (1) IL85167A (da)
MY (1) MY102312A (da)
NO (1) NO172493C (da)
NZ (1) NZ223296A (da)
PH (1) PH24478A (da)
PL (2) PL159842B1 (da)
PT (1) PT86613B (da)
SU (2) SU1591812A3 (da)
YU (2) YU46436B (da)
ZA (1) ZA88514B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3869630D1 (de) * 1987-01-27 1992-05-07 Pfizer 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate.
EP0961614A4 (en) * 1996-12-30 2002-07-24 Univ Bar Ilan OXYALKYLESTERS CONTAINING TRICARBOXYLIC ACID AND USES THEREOF
GB0128052D0 (en) * 2001-11-22 2002-01-16 Drug Discovery Lab As Compounds
US8187727B2 (en) 2005-07-22 2012-05-29 Lg Chem, Ltd. Imidazole derivatives, preparation method thereof and organic electronic device using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272439A (en) * 1978-06-02 1981-06-09 Schering Corporation 6-(Substituted-hydroxymethylene penams)
US4304779A (en) * 1979-05-09 1981-12-08 Schering Corporation 6-(Nitrogen-containing heterocyclic)hydroxymethylpenicillanic acids, compounds related thereto and processes for their preparation
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
GR77151B (da) * 1982-01-11 1984-09-07 Prizer
DD247677A5 (de) * 1984-01-30 1987-07-15 ������@���Kk�� Verfahren zur herstellung von 6-(subst.)-methylenpenicillan- und 6-(subst.)-hydroxymehtylpenicillansaeure und deren derivaten
EP0150984B1 (en) * 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
DE3869630D1 (de) * 1987-01-27 1992-05-07 Pfizer 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate.

Also Published As

Publication number Publication date
PT86613B (pt) 1991-12-31
HUT47118A (en) 1989-01-30
DK36788D0 (da) 1988-01-26
AU4883290A (en) 1990-05-17
SU1591812A3 (ru) 1990-09-07
AU613821B2 (en) 1991-08-08
IL85167A0 (en) 1988-07-31
CA1288091C (en) 1991-08-27
PH24478A (en) 1990-07-18
AU590142B2 (en) 1989-10-26
YU14488A (en) 1990-02-28
ES2031589T3 (es) 1992-12-16
CN88100588A (zh) 1988-08-10
PL161601B1 (pl) 1993-07-30
DK36788A (da) 1988-09-23
PL159842B1 (pl) 1993-01-29
MY102312A (en) 1992-05-28
KR880009030A (ko) 1988-09-13
PL270301A1 (en) 1988-12-08
YU46436B (sh) 1993-10-20
JPS63246384A (ja) 1988-10-13
IL85167A (en) 1994-01-25
HU205765B (en) 1992-06-29
IE60348B1 (en) 1994-06-29
FI880334A (fi) 1988-07-28
FI880334A0 (fi) 1988-01-26
EP0276942A1 (en) 1988-08-03
ZA88514B (en) 1989-09-27
NO880297L (no) 1988-07-28
DE3869630D1 (de) 1992-05-07
YU47020B (sh) 1994-11-15
SU1681730A3 (ru) 1991-09-30
DD279882A5 (de) 1990-06-20
YU124389A (en) 1990-12-31
CN1014710B (zh) 1991-11-13
GR3004460T3 (da) 1993-03-31
EP0276942B1 (en) 1992-04-01
IE880197L (en) 1988-07-27
NZ223296A (en) 1989-10-27
AU1074388A (en) 1988-07-28
KR900005050B1 (en) 1990-07-19
PT86613A (pt) 1988-02-01
ATE74359T1 (de) 1992-04-15
NO172493B (no) 1993-04-19
NO880297D0 (no) 1988-01-25

Similar Documents

Publication Publication Date Title
NO882608D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer.
HU9201033D0 (en) Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents
NO172493C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav
IL88740A (en) Pharmaceutical compositions containing n-n-butyl deoxynojirimycin for treating aids
EP0231087A3 (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants
EP0285284A3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
EP0280240A3 (en) Cephalosporin derivatives, process for their preparation and antibacterial agents
NO894325D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NZ235130A (en) Cephalosporin derivatives; oxygen and carbon analogues thereof; pharmaceutical compositions; methods of preparation and treatment
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
AU2013888A (en) Uricosuric composition
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen